• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

GSK Oncology Reps-Bye Bye

As far as the transition, it goes both ways. The vaccine folks now at GSK will be without jobs in no time. GSK isn't any better than Novartis when it comes to welcoming the newby, but try to remember that it isn't personal, it's in the best interest of the stock holders that we all go away.

Right, but that's not what is being talking about here. it's about stupid cross training, nothing to sell with, and no one giving any direction on where to go. Like we are being led by headless horsemen